Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.

Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P.

J Neuroimaging. 2010 Jan;20(1):9-15. doi: 10.1111/j.1552-6569.2009.00375.x. Epub 2009 May 19.

PMID:
19453837
2.

BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.

Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, Tüdös Z, Zapletalová J, Herzig R, Krobot A, Kaňovský P.

J Neurol Sci. 2012 Aug 15;319(1-2):89-95. doi: 10.1016/j.jns.2012.05.008. Epub 2012 Jun 9.

PMID:
22687958
3.

Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.

Veverka T, Hluštík P, Hok P, Otruba P, Tüdös Z, Zapletalová J, Krobot A, Kaňovský P.

J Neurol Sci. 2014 Nov 15;346(1-2):276-83. doi: 10.1016/j.jns.2014.09.009. Epub 2014 Sep 16.

PMID:
25255982
4.

Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.

Tomášová Z, Hluštík P, Král M, Otruba P, Herzig R, Krobot A, Kaňovský P.

J Neuroimaging. 2013 Jul;23(3):337-44. doi: 10.1111/j.1552-6569.2011.00682.x. Epub 2011 Dec 30.

PMID:
22212022
5.
6.

[Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].

Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.

Ann Readapt Med Phys. 2004 Oct;47(8):555-62. French.

PMID:
15465160
7.

Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.

Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM.

J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):217-21. Erratum in: J Neurol Neurosurg Psychiatry 2001 Jun;70(6):821.

8.

Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.

Boćkowski L, Okurowska-Zawada B, Sobaniec W, Kułak W, Sendrowski K.

Adv Med Sci. 2007;52 Suppl 1:171-5.

PMID:
18229658
9.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
10.

Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.

Rousseaux M, Kozlowski O, Froger J.

J Neurol. 2002 Jan;249(1):76-84.

PMID:
11954872
11.

Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.

Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A.

Arq Neuropsiquiatr. 2005 Mar;63(1):30-3. Epub 2005 Apr 13.

12.

Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.

Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.

Arch Phys Med Rehabil. 2008 May;89(5):799-806. doi: 10.1016/j.apmr.2008.01.007.

PMID:
18452724
13.

Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.

Gordon MF, Brashear A, Elovic E, Kassicieh D, Marciniak C, Liu J, Turkel C; BOTOX Poststroke Spasticity Study Group..

Neurology. 2004 Nov 23;63(10):1971-3.

PMID:
15557529
14.

Botulinum treatment for post-stroke spasticity: low dose regime.

Viriyavejakul A, Vachalathiti R, Poungvarin N.

J Med Assoc Thai. 1998 Jun;81(6):413-22.

PMID:
9676073
15.

Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.

Diserens K, Ruegg D, Kleiser R, Hyde S, Perret N, Vuadens P, Fornari E, Vingerhoets F, Seitz RJ.

Neurorehabil Neural Repair. 2010 Oct;24(8):753-62. doi: 10.1177/1545968310372138. Epub 2010 Jul 27.

PMID:
20663964
16.

Botulinum toxin type A in post-stroke upper limb spasticity.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group..

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.

PMID:
20569068
17.

Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.

Cousins E, Ward AB, Roffe C, Rimington LD, Pandyan AD.

Phys Ther. 2009 Jul;89(7):688-97. doi: 10.2522/ptj.20080040. Epub 2009 May 29.

PMID:
19482901
18.

Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.

Turkel CC, Bowen B, Liu J, Brin MF.

Arch Phys Med Rehabil. 2006 Jun;87(6):786-92.

PMID:
16731213
19.

Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.

Mayer NH, Whyte J, Wannstedt G, Ellis CA.

Arch Phys Med Rehabil. 2008 May;89(5):982-7. doi: 10.1016/j.apmr.2007.10.022.

PMID:
18452749
20.

Use of botulinum toxin in stroke patients with severe upper limb spasticity.

Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA.

J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):30-5.

Supplemental Content

Support Center